What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings
AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q2 2025 earnings on Jan 8, 2025. The consensus estimate for Q2 2025 revenue is $70.93 million, and the earnings are expected to come in at -$0.22 per share.
AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief
RPM International Achieves Record Q2 Results in Fiscal 2025
RPM International ( (RPM) ) has released its Q2 earnings. Here is a breakdown of the information RPM International presented to its
AngioDynamics: Fiscal Q2 Earnings Snapshot
AngioDynamics Inc. ANGO) on Wednesday reported a loss of $10.7 million in its fiscal second quarter. On a per-share basis, the Latham, New York-based company said it had a loss of 26 cents.
RPM International: Fiscal Q2 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.35 per share. The specialty chemicals company posted revenue of $1.85 billion in the period, also beating Street forecasts.
Compared to Estimates, RPM International (RPM) Q2 Earnings: A Look at Key Metrics
RPM International (RPM) reported $1.85 billion in revenue for the quarter ended November 2024, representing a year-over-year increase of 3%. EPS of $1.39 for the same period compares to $1.22 a year ago.
Zacks.com on MSN9h
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.05 per share a year ago. These figures are ...
AngioDynamics Inc. Q2 Loss Decreases, Beats Estimates
AngioDynamics Inc. (ANGO) revealed Loss for second quarter that decreased from last year but beat the Street estimates. The ...
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife(TM) System
Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding ...
Vanguard10d
Michael Ango: Revolutionizing revenue assurance in the FCT
In August 2024, President Bola Ahmed Tinubu appointed Mr. Michael Hadi Ango as the Acting Executive Chairman of the Federal ...
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...
Arise3d
Northern Elders’ Forum Demands Immediate Suspension of Proposed Tax Reform Bills
The Northern Elders’ Forum (NEF) on Saturday, demanded immediate suspension of the proposed Tax Reform Bills. The convener of NEF, Professor Ango Abdullahi, had in a communique issued after the ...